Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.73ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.73ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.73ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.73NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDZORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDZENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDZENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDZNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XEBORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XEBENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XEBENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XEBNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.263ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.263ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.263ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.263NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.180ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.180ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.180ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.180NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.464ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.464ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.464ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.464NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.234ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.234ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.234ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.234NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.231ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.231ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.231ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.231NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.243ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.243ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.243ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.243NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.517ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.517ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.517ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.517NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.291ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.291ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.291ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.291NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
B.1.258ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.349ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.349ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used